These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34253000)

  • 1. Rational approaches towards inorganic and organometallic antibacterials.
    Hess J
    Biol Chem; 2022 Mar; 403(4):363-375. PubMed ID: 34253000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thinking Outside the Box-Novel Antibacterials To Tackle the Resistance Crisis.
    Lakemeyer M; Zhao W; Mandl FA; Hammann P; Sieber SA
    Angew Chem Int Ed Engl; 2018 Oct; 57(44):14440-14475. PubMed ID: 29939462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Antimicrobial Photodynamic Therapy of Biofilm-Embedded and Intracellular Staphylococci with a Phage Endolysin's Cell Binding Domain.
    Bispo M; Santos SB; Melo LDR; Azeredo J; van Dijl JM
    Microbiol Spectr; 2022 Feb; 10(1):e0146621. PubMed ID: 35196798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials.
    Walesch S; Birkelbach J; Jézéquel G; Haeckl FPJ; Hegemann JD; Hesterkamp T; Hirsch AKH; Hammann P; Müller R
    EMBO Rep; 2023 Jan; 24(1):e56033. PubMed ID: 36533629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Potent Antibacterial Organometallic Peptide Conjugates.
    Albada B; Metzler-Nolte N
    Acc Chem Res; 2017 Oct; 50(10):2510-2518. PubMed ID: 28953347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Call for next-generation drugs that remove the uptake barrier to combat antibiotic resistance.
    Peng B; Li H; Peng XX
    Drug Discov Today; 2023 Oct; 28(10):103753. PubMed ID: 37640151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria.
    Hernandez V; Crépin T; Palencia A; Cusack S; Akama T; Baker SJ; Bu W; Feng L; Freund YR; Liu L; Meewan M; Mohan M; Mao W; Rock FL; Sexton H; Sheoran A; Zhang Y; Zhang YK; Zhou Y; Nieman JA; Anugula MR; Keramane el M; Savariraj K; Reddy DS; Sharma R; Subedi R; Singh R; O'Leary A; Simon NL; De Marsh PL; Mushtaq S; Warner M; Livermore DM; Alley MR; Plattner JJ
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1394-403. PubMed ID: 23295920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renaissance in Antibiotic Discovery: Some Novel Approaches for Finding Drugs to Treat Bad Bugs.
    Gadakh B; Van Aerschot A
    Curr Med Chem; 2015; 22(18):2140-58. PubMed ID: 25787965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources of novel antibiotics--aside the common roads.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    Appl Microbiol Biotechnol; 2010 Dec; 88(6):1261-7. PubMed ID: 20865256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Antibacterials: Alternatives to Traditional Antibiotics.
    Betts JW; Hornsey M; La Ragione RM
    Adv Microb Physiol; 2018; 73():123-169. PubMed ID: 30262108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unconventional Antibacterials and Adjuvants.
    Chang M; Mahasenan KV; Hermoso JA; Mobashery S
    Acc Chem Res; 2021 Feb; 54(4):917-929. PubMed ID: 33512995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs.
    Kim W; Hendricks GL; Lee K; Mylonakis E
    Expert Opin Drug Discov; 2017 Jun; 12(6):625-633. PubMed ID: 28402221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
    Liu Y; Li R; Xiao X; Wang Z
    Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of metal-based complexes as promising antimicrobial agents.
    Liang J; Sun D; Yang Y; Li M; Li H; Chen L
    Eur J Med Chem; 2021 Nov; 224():113696. PubMed ID: 34274828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic Chitosan Nano-Assembly as a Potent Alternative Candidate for Combating Antibiotic-Resistant Bacteria.
    Zhang R; Li Y; Zhou M; Wang C; Feng P; Miao W; Huang H
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26711-26721. PubMed ID: 31287648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.